en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Artykuły w druku O czasopiśmie Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury
1/2020
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
streszczenie artykułu:
Wytyczne/zalecenia

Uaktualnione wytyczne Polskiego Towarzystwa Okulistycznego dotyczące postępowania w retinopatii wcześniaków

Anna Gotz-Więckowska
1
,
Alina Bakunowicz-Łazarczyk
2
,
Wojciech Hautz
3
,
Erita Violetta Filipek
4
,
Anna Maria Niwald
5

1.
Department of Ophthalmology, Poznan University of Medical Sciences, Poznan, Poland
2.
Department of Pediatric Ophthalmology with Strabismus Treatment Centre, Medical University of Bialystok, Bialystok, Poland
3.
Department of Ophthalmology, Children’s Memorial Health Institute in Warsaw, Poland
4.
Teaching Department of Pediatric Ophthalmology in the Chair of Ophthalmology, Medical University of Silesia, Katowice, Poland
5.
Pediatric Ophthalmology Ward, Central Teaching Hospital of the Medical University of Lodz, Lodz, Poland
Data publikacji online: 2020/04/10
Pełna treść artykułu
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 


According to the consensus of Polish neonatologists and the Pediatric Ophthalmology Section of Polish Ophthalmological Society, screening for retinopathy of prematurity (ROP) should be performed in children born ≤ 33 weeks of gestational age with birth weight ≤ 1800 γ and in premature infants born over 33 weeks and weighing over 1800 γ with respiratory failure, low weight gain and other pathologies connected with prematurity qualified by the neonatologist due to the general condition and high risk of ROP. The recommended time of the first examination is in the 4th week of chronological age. Subsequent examinations should be performed at the intervals depending on the retinal vascularization in periods of one to three weeks. If a child is discharged from the hospital before a complete retinal vascularization, parents/guardians must be informed of the need for timely follow-up check-up ophthalmic visits.

In the treatment of ROP, laser photocoagulation of the avascular retina or intravitreal anti-VEGF injections (bevacizumab, ranibizumab, aflibercept) are used. Diode or argon laser therapy remains the method of choice for ROP treatment. Current global guidelines do not specify strict indications for the use of anti-VEGF therapy. Available observations suggest its effectiveness in the treatment of aggressive posterior ROP (APROP). Anti-VEGF therapy can be used in patients in whom photocoagulation is difficult or impossible, e.g. when corneal, lens or vitreous haze occurs, or when pupil dilatation is not possible.

Treatment should be performed no later than 72 hours after diagnosis. If retinal detachment occurs despite treatment, it is recommended to perform a vitrectomy in selected cases. Treatment is necessary for ROP type 1, defined as: 1. Any stage of ROP in zone I with plus disease, 2. Stage 3 ROP without plus disease in zone I, 3. Stage 2 or 3 with plus disease in zone II. Treatment for both eyes should be considered when ROP type 1 is present in only one eye.
© 2020 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe